0001144204-17-048544.txt : 20170918 0001144204-17-048544.hdr.sgml : 20170918 20170918180253 ACCESSION NUMBER: 0001144204-17-048544 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170914 FILED AS OF DATE: 20170918 DATE AS OF CHANGE: 20170918 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fiorino Anthony S. CENTRAL INDEX KEY: 0001608901 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36602 FILM NUMBER: 171090648 MAIL ADDRESS: STREET 1: C/O BRAINSTORM CELL THERAPEUTICS, INC. STREET 2: 605 THIRD AVENUE, 34TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001208261 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521841431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 430 EAST 29TH STREET STREET 2: SUITE 940 CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 646-440-9310 MAIL ADDRESS: STREET 1: 430 EAST 29TH STREET STREET 2: SUITE 940 CITY: NEW YORK STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: EPICEPT CORP DATE OF NAME CHANGE: 20021129 4 1 v475391_form4.xml FORM 4 X0306 4 2017-09-14 0 0001208261 IMMUNE PHARMACEUTICALS INC IMNP 0001608901 Fiorino Anthony S. C/O IMMUNE PHARMACEUTICALS INC. 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632 0 1 0 0 Chief Medical Officer and COO Stock Option 1.10 2017-09-14 4 A 0 90000 0 A 2017-09-14 2027-09-14 Common Stock 90000 90000 D 15% of the options shall vest ninety (90) days following the date of grant; 15% on the first-year anniversary of the date of grant (the "Anniversary") and 70% in equal portions at the end of each three (3) month period over the course of a two (2) year period commencing on the Anniversary. /s/ Anthony Fiorino 2017-09-18